// App-Quantinova.ai

256 : Analysis of combined drug effects on hENT1 and hENT4 in pancreatic cancer cells

Researchers

Presenter

  • Stancy J. Joseph

Principal Investigators

  • Beverly Word

  • Beverly Lyn-Cook

Medical Centers

  • NCTR/FDA, Jefferson, AR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Type 2 diabetes mellitus

  • Pancreatic cancer

  • Diabetes

  • Solid malignancies

Biomarkers

  • Human equilibrative nucleoside transporter 1

Drug/Treatment

  • I3C

  • Decitabine

  • Metformin controlled release

  • Gemcitabine

  • Metformin Hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved